BRIEF: Green Tea Group secures CSRC approval for Hong Kong IPO
Restaurant operator Green Tea Group Ltd. received an approval notice from the China Securities Regulatory Commission (CSRC) last Friday for its plan to list in Hong Kong — a necessary…
BRIEF: Tech stocks shine in Hang Seng Composite review, consumer and pharma lag
Hong Kong’s benchmark Hang Seng Index (HSI) remained unchanged at 83 constituents in the compiler’s latest adjustments, while the Hang Seng Composite Index’s (HSCI) constituents dropped from 517 to 505…
BRIEF: Sany Heavy plans Hong Kong listing to raise up to $1.5 billion
Shanghai-listed heavy equipment maker Sany Heavy Industry Co. Ltd. (600031.SH) announced on Wednesday it plans to make a second listing in Hong Kong as part of its global expansion, which…
BRIEF: Mixue clears Hong Kong listing hearing, aims for early March debut
Leading Chinese bubble tea seller Mixue Group passed its listing hearing with the Hong Kong Stock Exchange, according to its post-hearing information pack released last Friday. After achieving that key…
Hong Kong gains clout as preferred IPO watering hole for Chinese companies
The city is becoming the top destination for new Chinese listings, as China’s A-share market slows the pace of new IPOs and geopolitical factors make New York less attractive Key…
A new definition for independent directors – Part 2
Improving the Corporate Governance Code will provide much-needed reform for boards of listed companies, while also updating responsibilities for independent directors This is the second part of a two-part series…
Stimulus-fueled China stock rally set to fizzle?
The Hong Kong market’s nearly 20% jump in the week after Beijing unveiled major new stimulus measures looks based more on hopes than reality By Rene Vanguestaine It may…
Recent Articles
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK -
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
- Why aim small? 51World Digital Twin sets its sights on cloning Earth
